866-507-7254

NEWS

We have chosen the most important industry news.

Quick Filters

Results

ALL News Results

Alzheimer’s Association Welcomes U.S. FDA Approval of Lecanemab

January 23, 2023

Press Releases
CMS Statement on FDA Accelerated Approval of Lecanemab

January 23, 2023

Medicare
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

January 23, 2023

FDA Approvals
Lecanemab Confirmatory Phase 3 Clarity Ad Study Shows Significant Reduction of Clinical Decline

September 28, 2022

FDA Approvals
The Alzheimer’s Treatments, Diagnostics That Could Be Available Soon

August 10, 2022

FDA Approvals
Alzheimer’s Association Launches ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments

August 01, 2022

Press Releases
The Fight Against Alzheimer’s: Where Are We Now?

July 31, 2022

Care
The Changing Role of the Caregiver

July 19, 2022

Care
What It's Like Living with Alzheimer's

July 01, 2022

Care
Alzheimer’s Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer’s Disease

July 12, 2021

Medicare
Alzheimer’s Association Welcomes FDA Approval of Aducanumab

June 07, 2021

FDA Approvals

Find medical professionals in your area who are participating in ALZ-NET.

Find a Site